Planned Curbs on Telehealth Prescriptions Spark Backlash
WASHINGTON—A federal plan to resume tighter limits on the prescribing of controlled substances through telehealth has spurred a backlash from some medical and patient advocacy groups who say the requirements would create barriers to care.
The organizations are urging the Drug Enforcement Administration to reconsider proposed rules that would let doctors remotely prescribe a 30-day supply of some drugs, including buprenorphine for opioid-use disorder, as well as ketamine and testosterone, but require at least one in-person visit for further prescriptions.
WASHINGTON—A federal plan to resume tighter limits on the prescribing of controlled substances through telehealth has spurred a backlash from some medical and patient advocacy groups who say the requirements would create barriers to care.
The organizations are urging the Drug Enforcement Administration to reconsider proposed rules that would let doctors remotely prescribe a 30-day supply of some drugs, including buprenorphine for opioid-use disorder, as well as ketamine and testosterone, but require at least one in-person visit for further prescriptions.
Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.